Publications by authors named "Gerald Faich"

Claim this Profile
O
Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database.
Megan E McAuliffe, Stephan Lanes, Timothy Leach, Asit Parikh, Gerald Faich

Curr Med Res Opin· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned in the conduct of a global, large simple trial of treatments indicated for schizophrenia.
Francesca M Kolitsopoulos, Brian L Strom, Gerald Faich, Sybil M Eng, John M Kane

Contemp Clin Trials· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac safety of diabetes therapies and postmarketing requirements.
Gerald A Faich, Annette Stemhagen

Pharmacoepidemiol Drug Saf· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.
Brian L Strom, Gerald A Faich, Robert F Reynolds, Sybil M Eng, Ralph B D'Agostino

J Clin Psychiatry· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation.
Catherine B Johannes, Najat Ziyadeh, John D Seeger, Ed Tucker, Christoph Reiter, Gerald Faich

Drug Saf· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Points to consider: the roles of surveillance and epidemiology in advancing drug safety.
Ralph Edwards, Gerald Faich, Hugh Tilson,

Pharmacoepidemiol Drug Saf· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of parenteral iron and mortality among hemodialysis patients.
Harold I Feldman, Marshall Joffe, Bruce Robinson, Jill Knauss, Borut Cizman, Gerald Faich

J Am Soc Nephrol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical experience with moxifloxacin in patients with respiratory tract infections.
Gerald A Faich, Joel Morganroth, Alan B Whitehouse, Jugroop S Brar, Peter Arcuri

Ann Pharmacother· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib.
William B White, Gerald Faich, Jeffrey S Borer, Robert W Makuch

Am J Cardiol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron administration and clinical outcomes in hemodialysis patients.
Harold I Feldman, Jill Santanna, Wensheng Guo, Howard Furst, Eunice Franklin, Gerald Faich

J Am Soc Nephrol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac.
William B White, Gerald Faich, Andrew Whelton, Clement Maurath, Nancy J Ridge

Am J Cardiol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis